Is Basel Medical Group Ltd Ordinary Shares (BMGL) a Buy, Sell, or Hold?
Basel Medical Group Ltd Ordinary Shares
NASDAQ:BMGL
$8.12 USD
$1.71 (26.59%)
- Volume
- 566.89K
- Average Volume
- 55.89K
- Market Capitalization
- $12.71M
- P/E Ratio
- -29.94
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $36.60
- Year Low
- $4.60
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.88
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Yen Feng Chhoa |
| Industry | Medical - Care Facilities |
| Sector | Healthcare |
| Current Symbol | BMGL |
| CUSIP | G0864B111 |
| CIK | 0002004489 |
| Web | https://baselmedical.com |
| Phone | 65 6291 9188 |
| Currency | USD |
| Employees | 70 |
| Country | SG |
Liquidity
| Debt-to-Equity Ratio | 1.57 |
| Payout Ratio | 0.00 |
| Current Ratio | 1.88 |
| Quick Ratio | 1.84 |
| Cash Ratio | 0.18 |
Sales & Book Value
| Annual Sales | $11.32M |
| Price / Sales | 1.15 |
| Cash Flow | -1.64 |
| Price / Cash Flow | -6.37 |
| Price / Book | 2.61 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-5.16 |
| Trailing P/E Ratio | -29.94 |
| PEG Ratio | -0.30 |
| P/E Growth | -0.30 |
| Net Income | $-12.09M |
| Net Margin | -67.66% |
| Pretax Margin | -70.01% |
| Return on Equity | -173.64% |
| Return on Assets | -48.06% |
Financials Score
| AltmanZ Score | |
| Piotroski Score | |
| Working Capital | - |
| Total Assets | - |
| Ebit | - |
| Market Cap | - |
| Total Liabilities | - |
Poll Results
About Basel Medical Group Ltd Ordinary Shares (NASDAQ:BMGL) Stock
Basel Medical Group Ltd, an entity established in Singapore in 2023, is dedicated to delivering a comprehensive range of healthcare services. Its operations span multiple key areas, including specialist medical expertise, medical supplies and equipment, advanced medical technology solutions, and pharmaceutical products. ...
BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement
2026-07-10 06:30:00
Singapore, July 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the "Company") today announced that it has received notification from Nasdaq that the Company has regained compliance with the Nasdaq minimum bid price rule. On January 22, 2026, Nasdaq notified the Company that its ordinary shares failed to maintain a minimum bid price of $1.
BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement
2026-07-10 06:30:00
Singapore, July 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today announced that it has received notification from Nasdaq that the Company has regained compliance with the Nasdaq minimum bid price rule. On January 22, 2026, Nasdaq notified the Company that its ordinary shares failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Listing Rules of The Nasdaq Stock Market. Since then, Nasdaq has determined that for the last 10 consecutive business days, from June 23, 2026 to July 7, 2026, the closing bid price of the Company's ordinary shares has been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Listing Rule 5550(a)(2).
2026-06-10 09:05:00
BEIJING, June 10, 2026 /PRNewswire/ -- Recently, QingSong Health Corp (2661.HK) and Basel Medical Group Ltd announced the signing of a Memorandum of Strategic Cooperation. The two parties intend to explore cooperation in AI-enabled healthcare services, insurance-related healthcare solutions, and cross-border medical services in Southeast Asia.
BMGL to Effect Reverse Share Split on June 22, 2026
2026-06-10 07:00:00
SINGAPORE, June 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the "Company"), a medical clinic operator in Singapore, today announced that the Company's board of directors has approved the consolidation of the Company's issued and outstanding shares of the Company on a 1-for-12 ratio with the marketplace effective date of June 22, 2026.
BMGL to Effect Reverse Share Split on June 22, 2026
2026-06-10 07:00:00
SINGAPORE, June 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), a medical clinic operator in Singapore, today announced that the Company's board of directors has approved the consolidation of the Company's issued and outstanding shares of the Company on a 1-for-12 ratio with the marketplace effective date of June 22, 2026.
2026-04-23 19:25:00
LOS ANGELES, April 23, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Basel Medical Group Ltd (“Basel” or “the Company”) (NASDAQ: BMGL) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
2026-04-14 15:14:00
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Basel Medical Group Ltd. (NASDAQ: BMGL) resulting from allegations that Basel Medical may have issued materially misleading business information to the investing public. So what: If you purchased Basel Medical securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency.
Frequently Asked Questions
-
What is the current Basel Medical Group Ltd Ordinary Shares (BMGL) stock price?
-
Basel Medical Group Ltd Ordinary Shares(NASDAQ:BMGL) stock price is $8.12 in the last trading session. During the trading session, BMGL stock reached the peak price of $36.6 while $4.596 was the lowest point it dropped to. The percentage change in BMGL stock occurred in the recent session was 26.59% while the dollar amount for the price change in BMGL stock was $1.71.
-
BMGL's industry and sector of operation?
-
The NASDAQ listed BMGL is part of Medical - Care Facilities industry that operates in the broader Healthcare sector.
-
Who are the executives of BMGL?
-
Chun How Neo | Interim Chief Financial Officer
Yen Feng Chhoa | Chief Executive Officer
Boon Chye Tan | Chief Commercial Officer & Director
Keng Leong Fung | Executive Chairman of the Board
Jianing Lu | Group Chief Financial Officer -
How many employees does BMGL have?
-
Number of BMGL employees currently stands at 70. BMGL operates from 600 North Bridge Road, Singapore, CE 188778, SG.
-
Link for BMGL official website?
-
Official Website of BMGL is: https://baselmedical.com
-
How do I contact BMGL?
-
BMGL could be contacted at phone #65 6291 9188 and can also be accessed through its website. BMGL operates from 600 North Bridge Road, Singapore, CE 188778, SG.
-
How many shares of BMGL are traded daily?
-
The average number of BMGL shares traded daily for last 3 months was 55.89K.
-
What is the market cap of BMGL currently?
-
The market value of BMGL currently stands at $12.71M with its latest stock price at $8.12